Reported cannabinoid research / identity review ongoing
CBDH: reported identity research
This research-index record shows how CBDH has been described in cited chemical-identity research. It is a source map, not an independent chemistry verification and not a page about health effects.
Publication status
Research index published; compound identity not independently verified
A human approved publication of this source-linked record on July 24, 2026. That editorial decision allows the cited identity report and its locator to be indexed. It does not verify the chemical identity, approve a health claim, establish safety, or convert AI-assisted extraction into a scientific conclusion.
Reported in research
The page names the source, evidence role, and precise location used by the candidate registry.
Identity review
The compound remains in the registry-gated lane until a distinct human identity-verification decision is recorded.
Effects and safety
This identity record does not make a clinical, therapeutic, dosing, product, or personal-safety claim.
What the registry records
Source-linked identity summary
Our candidate registry summarizes the cited identity record this way: A six-carbon side-chain homolog of CBD reported in the FM2 medicinal Cannabis variety, isolated by semipreparative HPLC, and identified by comparison with an authentic stereoselectively synthesized standard.
This wording is deliberately limited to identity and occurrence. “Reported,” “isolated,” “detected,” or “characterized” describes what the cited paper says it did; those words do not mean Cannabinoid Encyclopedia independently repeated the laboratory work. The original source and locator below are the controlling evidence trail.
Candidate identity snapshot
Names and classification recorded for CBDH
| Field | Candidate registry value |
|---|---|
| Reported name | (-)-trans-cannabidihexol |
| Molecular formula | C22H32O2 |
| Registry family | Cannabidiol Homolog |
| Reported occurrence | Isolated From Cannabis |
| Registry subtype | Phytocannabinoid Homolog |
| Recorded aliases | cannabidihexol, (-)-trans-CBDH, cannabidiol hexyl homolog |
These fields help readers find the cited record and distinguish similarly named compounds. They remain candidate metadata while identity review is ongoing. A molecular formula or familiar abbreviation alone is not proof that two records describe the same material, stereochemistry, preparation, or natural occurrence.
Identity evidence trail
1 identity record from 1 peer-reviewed source
Each entry states why a source was connected to this candidate and where its support should be checked. Readers should inspect the cited paper when exact analytical methods, spectra, comparison standards, stereochemistry, or sample provenance matter.
Identity record 1
Isolation And Structure Elucidation
Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol
Linciano P, Citti C, Russo F, et al. / 2020-12-16
Support locator: Abstract; Results sections describing unambiguous identification of the n-hexyl homologs against authentic standards and isolation of natural CBDH by semipreparative HPLC with spectroscopic comparison to the synthetic standard.
Extraction: Ai Assisted; publication approved as a research-index record, not identity verification.
Candidate identity evidence extracted for human verification; no approval was applied.
Candidate identifiers
External identifiers are recorded with limits
| System | Value | Source note |
|---|---|---|
| PubChem CID | 140883953 | PubChem compound record matching the CBDH stereoisomer and formula; supports chemical identity, not natural occurrence. |
An identifier can help locate a database record. It does not by itself establish that a compound was naturally present in a sample, that a published structure assignment is final, or that a commercial product contains the reported compound.
Mandatory editorial note
What must stay attached to this record
Identity evidence is candidate-only until a human records a verification decision. Mouse findings and other pharmacology must remain separate from chemical identity and cannot establish human efficacy.
The source extraction was prepared for human review and the page publication was approved as a research-index record. A later identity decision may verify, revise, merge, exclude, or supersede this candidate. Corrections should preserve the prior evidence trail rather than silently overwriting it.
What this page cannot answer
Identity research is not an effects guide
- This page does not establish that CBDH has a health benefit or treats a condition.
- It does not establish human safety, intoxication risk, interactions, dosing, or suitability for any person.
- It does not verify a retail product, label, certificate of analysis, extract, or formulation.
- It does not transfer findings from THC, CBD, another cannabinoid, an animal model, or a laboratory assay to this candidate.
- It does not replace the original analytical paper or a qualified chemical review of that paper.
Continue the identity index
Related reported cannabinoid records
These links are navigation through the candidate registry, not evidence that the compounds are interchangeable.
(-)-trans-cannabidibutol
Identity review ongoing Research index CBDMcannabidiol monomethyl ether
Identity review ongoing Research index CBDP(-)-trans-cannabidiphorol
Identity review ongoing Research index (+/-)-3''-hydroxy-delta-(4'',5'')-CBC(+/-)-3''-hydroxy-delta-(4'',5'')-cannabichromene
Identity review ongoing Research index (+/-)-4-acetoxy-CBC(+/-)-4-acetoxycannabichromene
Identity review ongoing Research index (+/-)-6,7-cis-epoxy-CBG(+/-)-6,7-cis-epoxycannabigerol
Identity review ongoingCorrections and review
Help us improve the source trail
If a structure assignment has been corrected, a source has been retracted, an identifier is mismatched, or a stronger identity record exists, send the DOI or PMID and a precise locator. The editorial team can review the evidence and preserve the decision history.